HMG-CoA reductase inhibitor [orch, phsu]
Combined [qlco]
Hormone [horm]
Replacement therapy [topp]
Lipid Metabolism [moft]
Japanese [popg]
Women [popg]
Lipidaemia [dsyn]
DOUBLE BLIND [resa]
Controlled [ftcn]
Study, Prospective [resa]
objectives [inpr]
Menopause [phsf]
serum lipid [lbpr]
Concentrations [menp]
Compared [acty]
Regimen [topp]
Pravastatin [orch, phsu]
Alone [qnco]
Pravastatin [orch, phsu]
Hormone Therapy [topp]
postmenopausal [tmco]
Women [popg]
Hyperlipidaemia [dsyn]
Methods [inpr]
Performed [ftcn]
DOUBLE BLIND [resa]
randomized [resa]
Controlled [ftcn]
Study [mnob]
postmenopausal [tmco]
Women [popg]
Hyperlipidaemia [dsyn]
Women [popg]
Assigned [ftcn]
Receive [qlco]
Pravastatin [orch, phsu]
Alone [qnco]
M NOS [aapp, imft]
Group N [inpr]
Pravastatin [orch, phsu]
Hormone replacement therapy [topp]
Group [idcn]
N NOS [aapp, imft]
weeks [tmco]
serum lipid [lbpr]
Estrogen [horm, phsu, strd]
Concentrations [menp]
Measured [qlco]
baseline [bodm]
4 Weeks [tmco]
weeks [tmco]
treatment [ftcn]
Group [idcn]
baseline [bodm]
demographic [ocdi]
Characteristics [qlco]
Age [orga]
Height [orga]
Body Weight [orga]
Compared [acty]
baseline [bodm]
Total Cholesterol [lbpr]
Concentration [menp]
4 Weeks [tmco]
weeks [tmco]
M NOS [aapp, imft]
Group [idcn]
4 Weeks [tmco]
weeks [tmco]
Group [idcn]
Low Density Lipoprotein Cholesterol [bacs, strd]
Concentration [menp]
Decreased [qnco]
4 Weeks [tmco]
weeks [tmco]
M NOS [aapp, imft]
Group [idcn]
4 Weeks [tmco]
weeks [tmco]
Group [idcn]
serum cholesterol [lbpr]
Concentrations [menp]
Group [idcn]
M NOS [aapp, imft]
Group [idcn]
4 Weeks [tmco]
treatment [ftcn]
Group [idcn]
serum lipid [lbpr]
Concentrations [menp]
weeks [tmco]
Pravastatin [orch, phsu]
Combined [qlco]
Hormone replacement therapy [topp]
Suggest [idcn]
serum lipid [lbpr]
Concentrations [menp]
Pravastatin [orch, phsu]
Alone [qnco]
treatment [ftcn]
Group [idcn]
serum concentration [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglyceride [bacs, lipd]
Concentrations [menp]
Initiation [menp]
therapy [ftcn]
Group [idcn]
Correlation [qlco]
Percentage [qnco]
serum lipid [lbpr]
Concentrations [menp]
Estrogen [horm, phsu, strd]
Concentrations [menp]
Suggest [idcn]
Hormone replacement therapy [topp]
Induced [ftcn]
Estrone [horm, phsu, strd]
EL [gngm]
Estradiol [horm, phsu, strd]
E2 [gngm]
Contribute [acty]
Improved [qlco]
serum lipid [lbpr]
Profile [lbpr]
Total Cholesterol [lbpr]
E2 [gngm]
EL [gngm]
Negative [qlco]
Correlation [qlco]
weeks [tmco]
4 Weeks [tmco]
Pravastatin [orch, phsu]
apparent [idcn]
Endogenous [ftcn]
Estrogen [horm, phsu, strd]
side effects [ftcn]
confirmed [qlco]
Pravastatin [orch, phsu]
Alone [qnco]
Combination [qlco]
Hormone replacement therapy [topp]
Conclusions [idcn]
Combination [qlco]
Pravastatin [orch, phsu]
Hormone replacement therapy [topp]
Management [ocac]
Hyperlipidaemia [dsyn]
postmenopausal [tmco]
Women [popg]
Very [qlco]
Broad [spco]
Benefits [qnco]
Hormone replacement therapy [topp]
compromise [fndg]
Lipid [lipd]
lowering [spco]
effects [qlco]
treatment [ftcn]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
